Compare MTRN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTRN | PBH |
|---|---|---|
| Founded | 1931 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2000 | 2004 |
| Metric | MTRN | PBH |
|---|---|---|
| Price | $177.45 | $57.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $52.50 | ★ $75.33 |
| AVG Volume (30 Days) | 164.6K | ★ 497.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.31% | N/A |
| EPS Growth | ★ 1178.57 | 2.88 |
| EPS | ★ 3.58 | 2.78 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $15.31 | N/A |
| Revenue Next Year | $7.57 | $4.31 |
| P/E Ratio | $50.39 | ★ $21.06 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $70.94 | $51.24 |
| 52 Week High | $183.96 | $88.00 |
| Indicator | MTRN | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 68.01 | 44.73 |
| Support Level | $119.57 | $57.25 |
| Resistance Level | N/A | $63.56 |
| Average True Range (ATR) | 5.72 | 2.12 |
| MACD | 2.79 | 0.48 |
| Stochastic Oscillator | 81.65 | 70.91 |
Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.